(Q36822025)

16 August 2017

1 reference

title

Invasive candidiasis in pediatric intensive care patients: epidemiology, risk factors, management, and outcome (English)

1 reference

16 August 2017

1 reference

1 reference

4

Emmanuel Roilides

1 reference

16 August 2017

Joanna Filioti

1

1 reference

16 August 2017

Kleomenis Spiroglou

series ordinal

2

1 reference

16 August 2017

Christos P Panteliadis

series ordinal

3

1 reference

16 August 2017

publication date

15 May 2007

1 reference

16 August 2017

published in

Intensive Care Medicine

1 reference

16 August 2017

volume

33

1 reference

16 August 2017

issue

7

1 reference

16 August 2017

page(s)

1272-1283

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-007-0672-5

16 August 2017

exact match

0 references

cites work

The impact of candidemia on length of hospital stay, outcome, and overall cost of illness.

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Candidemia in a pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Frequency of fungemia in hospitalized pediatric inpatients over 11 years at a tertiary care institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Candida infections in children treated with conventional chemotherapy for solid tumors (transplant recipients excluded): The Institut Gustave Roussy Pediatrics Department experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Risk factors for disseminated candidiasis in children with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Emergence of Candida parapsilosis as the predominant species causing candidemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Vertical and horizontal transmission of unique Candida species to premature newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Hospital-acquired candidaemia: experience from a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Candidiasis among non-neutropenic patients: from colonization to infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Practices in non-neutropenic ICU patients with Candida-positive airway specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Should vascular catheters be removed from all patients with candidemia? An evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Amphotericin B nephrotoxicity in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Advances in antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Antifungal treatment in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

New agents for invasive mycoses in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Candidal meningitis in neonates: a 10-year review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Retrospective study of the safety of caspofungin in immunocompromised pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Use of amphotericin B colloidal dispersion in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Eradication of severe neonatal systemic candidiasis with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Fluconazole in combination with flucytosine in the treatment of fluconazole-resistant Candida infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Subtherapeutic ocular penetration of caspofungin and associated treatment failure in Candida albicans endophthalmitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Treatment with caspofungin in immunocompromised paediatric patients: a multicentre survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

In vitro activities of voriconazole, posaconazole, and fluconazole against 4,169 clinical isolates of Candida spp. and Cryptococcus neoformans collected during 2001 and 2002 in the ARTEMIS global antifungal surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida spp

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Reply to Dr. Chandrasekar (Clin Infect Dis 2001; 32:320-1) and Drs. Marr and Boeckh (Clin Infect Dis 2001; 32:321).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Microbiological factors influencing the outcome of nosocomial bloodstream infections: a 6-year validated, population-based model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Risk factors for mortality in children with candidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

A prospective study on fungal infection in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Infections diagnosed in the first year after pediatric stem cell transplantation

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

21 January 2018

12 December 2020

Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities

1 reference

https://api.crossref.org/works/10.1007%2FS00134-007-0672-5

Does candiduria predict candidaemia?

21 January 2018

1 reference

12 December 2020

Candidemia in the pediatric patient with burns

1 reference

12 December 2020

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

12 December 2020

Risk factors for candidemia in a children's hospital

1 reference

12 December 2020

Treatment of candidal infections with fluconazole in neonates and infants

1 reference

12 December 2020

Mortality associated with systemic candidiasis in children

1 reference

12 December 2020

Pediatric nosocomial fungal infections

1 reference

12 December 2020

Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients

1 reference

12 December 2020

Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis

1 reference

12 December 2020

Efficacy of amphotericin B lipid complex in the treatment of invasive fungal infections in immunosuppressed paediatric patients.

1 reference

12 December 2020

Disseminated nosocomial candidiasis in a pediatric intensive care unit.

1 reference

12 December 2020

Guidelines for the management of intravascular catheter-related infections

1 reference

12 December 2020

Candida infection in pediatric liver transplant recipients

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

Candidemia in pediatric surgery patients

1 reference

12 December 2020

Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.

1 reference

12 December 2020

National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units

1 reference

12 December 2020

Epidemiologic analysis and antifungal susceptibility of Candida blood isolates in southern Taiwan.

1 reference

12 December 2020

Prophylactic antifungal therapy in the intensive care unit

1 reference

12 December 2020

Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group

1 reference

12 December 2020

Fungal peritonitis in pediatric patients.

1 reference

12 December 2020

Candidemia in a pediatric intensive care unit

1 reference

12 December 2020

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

1 reference

12 December 2020

Incidence and mortality of proven invasive Candida infections in pediatric intensive care patients

1 reference

12 December 2020

10.1007/S00134-007-0672-5

Identifiers

DOI

1 reference

16 August 2017

1 reference